PropertyValue
?:abstract
  • A recent report found that rare predicted loss-of-function (pLOF) variants across 13 candidate genes in TLR3- and IRF7-dependent type I IFN pathways explain up to 3.5% of severe COVID-19 cases. We performed whole-exome or whole-genome sequencing of 1,934 COVID-19 cases (713 with severe and 1,221 with mild disease) and 15,251 ancestry-matched population controls across four independent COVID-19 biobanks. We then tested if rare pLOF variants in these 13 genes were associated with severe COVID-19. We identified only one rare pLOF mutation across these genes amongst 713 cases with severe COVID-19 and observed no enrichment of pLOFs in severe cases compared to population controls or mild COVID-19 cases. We find no evidence of association of rare loss-of-function variants in the proposed 13 candidate genes with severe COVID-19 outcomes.
is ?:annotates of
?:creator
?:doi
  • 10.1101/2020.12.18.20248226
?:doi
?:journal
  • medRxiv
?:license
  • cc-by-nd
?:pdf_json_files
  • document_parses/pdf_json/ae7a1baace8a29d9ace2fa751b757b056510acd0.json; document_parses/pdf_json/0fe9e0cc61d7e6e00dd443f62439fb94b1ca1b4d.json
?:pmc_json_files
  • document_parses/pmc_json/PMC7781338.xml.json
?:pmcid
?:pmid
?:pmid
  • 33398295.0
?:publication_isRelatedTo_Disease
?:sha_id
?:source
  • MedRxiv; Medline; PMC; WHO
?:title
  • Failure to replicate the association of rare loss-of-function variants in type I IFN immunity genes with severe COVID-19
?:type
?:year
  • 2020-12-21

Metadata

Anon_0  
expand all